Today's Updates

Belzutifan Plus Pembro Approved for Adjuvant RCC
Published Date: 13 Jun 2026

LITESPARK-022 trial reports a 28% decrease in risk for disease recurrence or death.

Read More

Latest News


Latest News

News All Time


Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Researchers publish action plan to address appendiceal cancer enigmas

2.

Daily physical activity, even at light intensities, linked to lower cancer risk

3.

Ketamine plus psychotherapy for "excellent" PTSD

4.

Adding cell-based vaccine to liver cancer therapy can slow cancer progression

5.

Telemedicine Not Reaching Rural Psychiatric Patients



© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot